The table below shows Mirum Pharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$228.76M
-$1.96M
$15.21M
-$18.77M
-$39.67M
-$25.21M
Capital expenditure
$664.00K
$41.00K
$13.00K
$41.00K
$0.00
$3.00K
Investing cash flow
-$11.57M
-$16.13M
-$13.00K
$27.02M
$36.50M
-$32.78M
Dividends paid
-
-
-
-
MIRM operating cash flow (10-K history)
Mirum Pharmaceuticals, Inc. reported operating cash flow of $55.83M for fiscal year 2025. That is up 440.7% from $10.32M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$39.36M (FY 2019) to $55.83M. Figures come from the company's audited annual reports as filed with the SEC.
